Pharma News: Vivus, Inc. (VVUS)’s Contract, Arena Pharmaceuticals, Inc. (ARNA) & Amgen, Inc. (AMGN)’s Financial Results

Page 1 of 2

Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG)

VIVUS, Inc. (NASDAQ:VVUS)VIVUS Announces Commercial Supply Agreement With Sanofi to Produce Avanafil (MarketWatch)
VIVUS, Inc. (NASDAQ:VVUS) -1.13% today announced that it has entered into a Commercial Supply Agreement with Sanofi Chimie (“Sanofi”), a wholly owned subsidiary of Sanofi, to manufacture and supply the active pharmaceutical ingredient (API) for avanafil on an exclusive basis in the United States and other territories and on a semi-exclusive basis in the European Union and Latin America. …”Sanofi was the logical choice for avanafil API manufacturing,” stated Theodore Broman, vice president, chemistry manufacturing and control, VIVUS, Inc. (NASDAQ:VVUS). ”Their world-class manufacturing capabilities and facilities are well-suited to undertake the worldwide production of avanafil.” The qualification and subsequent approval by regulatory authorities is expected to be completed no later than June 30, 2015. Until such approvals, VIVUS, Inc. (NASDAQ:VVUS) and its partners will continue to source avanafil API from Mitsubishi Tanabe Pharma Corporation.

Arena Pharma’s Q2 Earnings Soar (Zacks)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) earnings (excluding special items) of 17 cents per share in the second quarter of 2013 were higher than the breakeven earnings reported a year ago. Second quarter earnings also beat the Zacks Consensus Estimate of 13 cents. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) recorded second quarter revenues of $68.9 million, a massive increase of 213% from the year-ago period, thanks to a $65 million milestone payment received from partner Eisai related to Belviq. In Jun 2013, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) launched its obesity drug, Belviq, in the U.S. Second quarter results reflect the first three weeks of Belviq sales after its launch with Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) recording Belviq sales of $1.3 million. About 12,500 prescriptions for Belviq were written until Jul 19.

Why Has Amgen, Inc. (NASDAQ:AMGN) Stock Suffered Despite Posting Better Earnings? (BasicsMedia)
Amgen, Inc. (NASDAQ:AMGN) has been in business since 1980, during which time it has managed to grow large enough and employ more than 18k personnel. It is based in Thousand Oaks, California and is a well known company in the production of biotechnology medicines which it sells in the U.S, Europe and Canada. For the better part, whenever a company posts financial results which seem to favor investors, it would not be wrong to think of this as being the precursor to good news in terms of stock price and dividends. Amgen, Inc. (NASDAQ:AMGN) appears to have experienced the reverse. Why is this so? Did Amgen, Inc. (NASDAQ:AMGN) Declare Profits or Not? If you take a close look at the financial results which were posted by Amgen, Inc. (NASDAQ:AMGN), you would discover one thing, that they all indicated the company made profits.

VIVUS Announces Date of Second Quarter 2013 Financial Results and Conference Call (Virtual-Strategy)
VIVUS, Inc. (NASDAQ:VVUS) today announced that it will report financial results for the second quarter ended June 30, 2013 after the Nasdaq Market closes on Tuesday, August 6, 2013. The company will conduct a conference call and an audio webcast at 4:30pm EDT the same day. …VIVUS, Inc. (NASDAQ:VVUS) is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health. For more information about the company, please visit www.vivus.com.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!